SANDOSTATIN Side Effects

6998398-3 | Rash Erythematous, Rash Papular, Schamberg's Disease, Skin Lesion
on Sep 13, 2010 Male patient from GERMANY , weighting 169.8 lb, was diagnosed with acromegaly and was treated with Sandostatin (View Usage). Patient experienced the following unwanted or unexpected effects: rash erythematous, rash papular, schamberg's disease, skin lesion. Sandostatin dosage: . Patient was hospitalized.

6960084-3 | White Blood Cell Count Decreased
Patient was taking Sandostatin (View Usage). Patient had the following side effects: white blood cell count decreased on Aug 20, 2010 from JAPAN Additional patient health information: Male patient , 55 years of age, was diagnosed with gastrointestinal obstruction, gastric cancer and. Sandostatin dosage: 300 Ug/day. During the same period patient was treated with TS 1 (View Ts 1 Review and Ts 1 Label ), CISPLATIN (6 Mg/m^2) (View Cisplatin Review and Cisplatin Label ).

6956177-7 | International Normalised Ratio Increased, Prothrombin Time Shortened
Adverse event was reported on Aug 18, 2010 by a Female patient taking Sandostatin (View Usage) (Dosage: Unk) was diagnosed with carcinoid syndrome, atrial fibrillation (What is atrial fibrillation?) and. Location: BELGIUM , 84 years of age, After Sandostatin was administered, patient had the following side effects: international normalised ratio increased, prothrombin time shortened. During the same period patient was treated with MARCUMAR (1.5 Mg Daily) (View Marcumar Review and Marcumar Label ), CITALOPRAM (View Citalopram Review and Citalopram Label ), BETASERC (View Betaserc Review and Betaserc Label ), ALDACTAZINE (View Aldactazine Review and Aldactazine Label ), PERINDOPRIL ERBUMINE (View Perindopril Erbumine Review and Perindopril Erbumine Label ), LANOXIN (View Lanoxin Review and Lanoxin Label ), ZANTAC (View Zantac Review and Zantac Label ), PRAREDUCT (View Prareduct Review and Prareduct Label ).

6927618-6 | Arthralgia, Glucose Tolerance Impaired, Glucose Tolerance Test Abnormal, Glycosylated Haemoglobin Increased, Headache, Hyperhidrosis, Malaise, Oedema, Sebaceous Glands Overactivity
on Aug 03, 2010 Female patient from JAPAN , 57 years of age, weighting 130.1 lb, was treated with Sandostatin (View Usage). Patient experienced the following unwanted or unexpected effects: arthralgia, glucose tolerance impaired, glucose tolerance test abnormal, glycosylated haemoglobin increased, headache (What is headache?), hyperhidrosis, malaise, oedema, sebaceous glands overactivity. Sandostatin dosage: 200 Mcg/day. During the same period patient was treated with SANDOSTATIN LAR (400 Mg/month) (View Sandostatin Lar Review and Sandostatin Lar Label ).


6911285-1 | Caesarean Section, Neoplasm Progression, Normal Newborn, Visual Field Defect
on Jul 30, 2010 Female patient from FRANCE , weighting 136.7 lb, was diagnosed with acromegaly and was treated with Sandostatin (View Usage). Patient had the following side effects: caesarean section, neoplasm progression, normal newborn, visual field defect. Sandostatin dosage: 200 Microg Daily With A Pump.

6879984-8 | Ammonia Increased, Hepatic Encephalopathy, Malaise
Patient was taking Sandostatin (View Usage). After Sandostatin was administered, patient had the following side effects: ammonia increased, hepatic encephalopathy, malaise on Jul 16, 2010 from JAPAN Additional patient health information: Female patient , weighting 154.3 lb, was diagnosed with hepatic neoplasm and. Sandostatin dosage: 100 Ug, Qd.

6860231-8 | Aphagia, Fistula Discharge
Adverse event was reported on Jul 06, 2010 by a Male patient taking Sandostatin (View Usage) (Dosage: 0.05 Mg/day) was diagnosed with intestinal fistula and. Location: BRAZIL , 81 years of age, weighting 110.2 lb, Patient experienced the following unwanted or unexpected effects: aphagia, fistula discharge.

6836929-4 | Dyspnoea, Nausea
on Jun 16, 2010 Female patient from PHILIPPINES , 16 years of age, was treated with Sandostatin (View Usage). Patient had the following side effects: dyspnoea, nausea (What is nausea?). Sandostatin dosage: 100 Ug, Unk. During the same period patient was treated with SANDOSTATIN LAR (View Sandostatin Lar Review and Sandostatin Lar Label ).

6767452-3 | Abdominal Distension, Abdominal Pain, Decreased Appetite, Diarrhoea, Frequent Bowel Movements, Hepatic Embolisation, Hepatic Enzyme Increased, Liver Carcinoma Ruptured, Malignant Neoplasm Progression
on Jun 01, 2010 Female patient from JAPAN , 59 years of age, was diagnosed with carcinoid tumour and was treated with Sandostatin (View Usage). After Sandostatin was administered, patient had the following side effects: abdominal distension, abdominal pain (What is abdominal pain?), decreased appetite, diarrhoea, frequent bowel movements, hepatic embolisation, hepatic enzyme increased, liver carcinoma ruptured, malignant neoplasm progression. Sandostatin dosage: 100 Ug Daily. During the same period patient was treated with SANDOSTATIN LAR (Unk) (View Sandostatin Lar Review and Sandostatin Lar Label ). Patient was hospitalized.

6766199-7 | Rash Erythematous, Rash Papular, Schamberg's Disease, Skin Lesion
Patient was taking Sandostatin (View Usage). Patient experienced the following unwanted or unexpected effects: rash erythematous, rash papular, schamberg's disease, skin lesion on Jun 02, 2010 from GERMANY Additional patient health information: Male patient , weighting 169.8 lb, was diagnosed with acromegaly and. Sandostatin dosage: . Patient was hospitalized.

6734228-2 | Ascites, Aspartate Aminotransferase Increased, Blood Albumin Decreased, Blood Lactate Dehydrogenase Increased, Dysuria, Haematocrit Decreased, Haemoglobin Decreased, Neutrophil Count Increased, Platelet Count Increased
Adverse event was reported on May 07, 2010 by a Male patient taking Sandostatin (View Usage) (Dosage: 300 Ug Daily) was diagnosed with gastrointestinal obstruction and. Location: JAPAN , 52 years of age, Patient had the following side effects: ascites, aspartate aminotransferase increased, blood albumin decreased, blood lactate dehydrogenase increased, dysuria, haematocrit decreased, haemoglobin decreased, neutrophil count increased, platelet count increased. During the same period patient was treated with ELEMENMIC (Unk) (View Elemenmic Review and Elemenmic Label ), LACTEC (Unk) (View Lactec Review and Lactec Label ), DEXART (Unk) (View Dexart Review and Dexart Label ), DUROTEP (Unk) (View Durotep Review and Durotep Label ), ANPEC (Unk) (View Anpec Review and Anpec Label ), ROHYPNOL (Unk) (View Rohypnol Review and Rohypnol Label ), FULCALIQ (Unk) (View Fulcaliq Review and Fulcaliq Label ).

6721842-3 | Asthenia, Blood Pressure Abnormal, Breath Holding, Chest Discomfort, Heart Rate Decreased, Hyperhidrosis, Palpitations, Sinus Bradycardia
on Mar 08, 2010 Male patient from CHINA , 40 years of age, was treated with Sandostatin (View Usage). After Sandostatin was administered, patient had the following side effects: asthenia, blood pressure abnormal, breath holding, chest discomfort, heart rate decreased, hyperhidrosis, palpitations, sinus bradycardia. Sandostatin dosage: 0.2 Mg. During the same period patient was treated with SALINE (100 Ml) (View Saline Review and Saline Label ), OMEPRAZOLE (40 Mg, Q12h) (View Omeprazole Review and Omeprazole Label ), GLUCOSE (500 Ml) (View Glucose Review and Glucose Label ), VITAMIN K3 (20 Mg) (View Vitamin K3 Review and Vitamin K3 Label ), MAGNESIUM SULFATE (10 Ml) (View Magnesium Sulfate Review and Magnesium Sulfate Label ), PHLOROGLUCINOL (80 Mg) (View Phloroglucinol Review and Phloroglucinol Label ), CEFTAZIDIME (3 G, Bid) (View Ceftazidime Review and Ceftazidime Label ), TINIDAZOLE (200 Ml, Qd) (View Tinidazole Review and Tinidazole Label ). Patient was hospitalized.

6704541-3 | Chills, Irritability, Nausea, Stupor
on Apr 22, 2010 Female patient from KOREA, REPUBLIC OF , 64 years of age, was diagnosed with postoperative care and was treated with Sandostatin (View Usage). Patient experienced the following unwanted or unexpected effects: chills, irritability, nausea (What is nausea?), stupor. Sandostatin dosage: 0.3 Mg/day. During the same period patient was treated with VITAMIN K TAB (Unk) (View Vitamin K Tab Review and Vitamin K Tab Label ), CURAN (Unk) (View Curan Review and Curan Label ), MUCOSTEN (Unk) (View Mucosten Review and Mucosten Label ), CEFOTIAM (Unk) (View Cefotiam Review and Cefotiam Label ), ISEPACIN (Unk) (View Isepacin Review and Isepacin Label ), FUTHAN (Unk) (View Futhan Review and Futhan Label ).

6700677-1 | Agranulocytosis, Bacterial Infection
Patient was taking Sandostatin (View Usage). Patient had the following side effects: agranulocytosis, bacterial infection (What is bacterial infection?) on Apr 21, 2010 from GERMANY Additional patient health information: Male patient , 60 years of age, weighting 121.3 lb, . Sandostatin dosage: 3x100 Microgram Daily. During the same period patient was treated with KETAMINE (10-200 Mg Daily) (View Ketamine Review and Ketamine Label ), CATAPRESAN (0.3-1.7 Mg Daily) (View Catapresan Review and Catapresan Label ), FUROSEMIDE ^RATIOPHARM^ (40-400 Mg Daily) (View Furosemide ^ratiopharm^ Review and Furosemide ^ratiopharm^ Label ), PIPERACILLIN AND TAZOBACTAM (2 Df, Daily) (View Piperacillin And Tazobactam Review and Piperacillin And Tazobactam Label ), HALOPERIDOL ^GRY^ (3x 0.5 Mg, Daily) (View Haloperidol ^gry^ Review and Haloperidol ^gry^ Label ), VESDIL (2.5-10 Mg Daily) (View Vesdil Review and Vesdil Label ).

6695069-8 | Blood Pressure Systolic Increased, Cyanosis, Hypertension, Hypertensive Crisis, Skin Disorder, Tachycardia
Adverse event was reported on Apr 14, 2010 by a Male patient taking Sandostatin (View Usage) (Dosage: 200 Mg, Tid) was diagnosed with hypertension and. Location: FRANCE , 53 years of age, After Sandostatin was administered, patient had the following side effects: blood pressure systolic increased, cyanosis, hypertension, hypertensive crisis, skin disorder, tachycardia. During the same period patient was treated with ESOMEPRAZOLE (Unk) (View Esomeprazole Review and Esomeprazole Label ), IMIPENEM (Unk) (View Imipenem Review and Imipenem Label ), NEFORPAM (Unk) (View Neforpam Review and Neforpam Label ).

6691867-5 | Diabetes Mellitus, Glycosylated Haemoglobin Increased, Nausea, Nephropathy
on Apr 13, 2010 Male patient from JAPAN , 47 years of age, weighting 202.8 lb, was diagnosed with acromegaly and was treated with Sandostatin (View Usage). Patient experienced the following unwanted or unexpected effects: diabetes mellitus, glycosylated haemoglobin increased, nausea (What is nausea?), nephropathy. Sandostatin dosage: 50 Ug Per Day. During the same period patient was treated with INSULIN (Unk) (View Insulin Review and Insulin Label ), PIOGLITAZONE (30 Mg Per Day) (View Pioglitazone Review and Pioglitazone Label ), BROMOCRIPTINE (10 Mg Daily) (View Bromocriptine Review and Bromocriptine Label ), GLIBENCLAMIDE (0.625 Mg Daily) (View Glibenclamide Review and Glibenclamide Label ), VOGLIBOSE (0.6 Mg Per Day) (View Voglibose Review and Voglibose Label ), PEGVISOMANT (10 Mg Per Day) (View Pegvisomant Review and Pegvisomant Label ).

6683046-2 | Blood Glucose Decreased, Post Procedural Infection
on Apr 06, 2010 Female patient from JAPAN , 52 years of age, was diagnosed with pancreatic leak and was treated with Sandostatin (View Usage). Patient had the following side effects: blood glucose decreased, post procedural infection. Sandostatin dosage: 300 Ug, Tid.

6656541-X | Cytomegalovirus Infection, Herpes Simplex, Listeriosis, Loss Of Consciousness, Lung Disorder, Meningitis, Paraneoplastic Syndrome, Pneumocystis Jiroveci Infection, Pneumonia
Patient was taking Sandostatin (View Usage). After Sandostatin was administered, patient had the following side effects: cytomegalovirus infection (What is cytomegalovirus infection?), herpes simplex (What is herpes simplex?), listeriosis, loss of consciousness, lung disorder, meningitis (What is meningitis?), paraneoplastic syndrome, pneumocystis jiroveci infection, pneumonia (What is pneumonia?) on Mar 22, 2010 from GERMANY Additional patient health information: Female patient , weighting 131.2 lb, was diagnosed with thymoma and. Sandostatin dosage: 30 Mg/ 2 Weeks. During the same period patient was treated with PREDNISOLON (30 Mg) (View Prednisolon Review and Prednisolon Label ). Patient was hospitalized.

6655918-6 | Blood Glucose Decreased, Post Procedural Infection
Adverse event was reported on Mar 18, 2010 by a Female patient taking Sandostatin (View Usage) (Dosage: 300 Ug, Tid) was diagnosed with pancreatic leak and. Location: JAPAN , 52 years of age, Patient experienced the following unwanted or unexpected effects: blood glucose decreased, post procedural infection.

6634049-5 | Erythema, Eye Swelling
on Mar 11, 2010 Female patient from UNITED STATES , weighting 106.6 lb, was diagnosed with carcinoid syndrome and was treated with Sandostatin (View Usage). Patient had the following side effects: erythema, eye swelling. Sandostatin dosage: 0.05 Mg/ml, Unk.

6617758-3 | Rash Erythematous, Rash Papular, Schamberg's Disease, Skin Lesion
on Mar 01, 2010 Male patient from GERMANY , weighting 169.8 lb, was diagnosed with acromegaly and was treated with Sandostatin (View Usage). After Sandostatin was administered, patient had the following side effects: rash erythematous, rash papular, schamberg's disease, skin lesion. Sandostatin dosage: . Patient was hospitalized.

6602107-7 | Erythema, Eye Swelling
Patient was taking Sandostatin (View Usage). Patient experienced the following unwanted or unexpected effects: erythema, eye swelling on Feb 15, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 106.6 lb, was diagnosed with carcinoid syndrome and. Sandostatin dosage: 0.05 Mg/ml, Unk.

6602099-0 | Erythema, Eye Swelling
Adverse event was reported on Feb 15, 2010 by a Female patient taking Sandostatin (View Usage) (Dosage: 0.05 Mg/ml, Unk) was diagnosed with carcinoid syndrome and. Location: UNITED STATES , weighting 106.6 lb, Patient had the following side effects: erythema, eye swelling.

6591235-0 | Listeriosis, Loss Of Consciousness, Lung Disorder, Meningitis, Pyrexia, Sepsis
on Feb 12, 2010 Female patient from GERMANY , weighting 131.2 lb, was diagnosed with thymoma and was treated with Sandostatin (View Usage). After Sandostatin was administered, patient had the following side effects: listeriosis, loss of consciousness, lung disorder, meningitis (What is meningitis?), pyrexia, sepsis (What is sepsis?). Sandostatin dosage: 30 Mg/ 2 Weeks. During the same period patient was treated with PREDNISOLON (30 Mg) (View Prednisolon Review and Prednisolon Label ). Patient was hospitalized.

6572104-9 | Arthralgia, Glucose Tolerance Test Abnormal, Glycosylated Haemoglobin Increased, Headache, Hyperhidrosis, Malaise, Oedema, Sebaceous Glands Overactivity
on Jan 22, 2010 Female patient from JAPAN , 57 years of age, weighting 130.1 lb, was treated with Sandostatin (View Usage). Patient experienced the following unwanted or unexpected effects: arthralgia, glucose tolerance test abnormal, glycosylated haemoglobin increased, headache (What is headache?), hyperhidrosis, malaise, oedema, sebaceous glands overactivity. Sandostatin dosage: 200 Mcg/day. During the same period patient was treated with SANDOSTATIN LAR (400 Mg/month) (View Sandostatin Lar Review and Sandostatin Lar Label ).

6570953-4 | Arthralgia, Glucose Tolerance Test Abnormal, Glycosylated Haemoglobin Increased, Headache, Hyperhidrosis, Malaise, Oedema, Sebaceous Glands Overactivity
Patient was taking Sandostatin (View Usage). Patient had the following side effects: arthralgia, glucose tolerance test abnormal, glycosylated haemoglobin increased, headache (What is headache?), hyperhidrosis, malaise, oedema, sebaceous glands overactivity on Jan 22, 2010 from JAPAN Additional patient health information: Female patient , 57 years of age, weighting 130.1 lb, . Sandostatin dosage: 200 Mcg/day. During the same period patient was treated with SANDOSTATIN LAR (400 Mg/month) (View Sandostatin Lar Review and Sandostatin Lar Label ).

6567865-9 | Rash Erythematous, Rash Papular, Schamberg's Disease, Skin Lesion
Adverse event was reported on Jan 21, 2010 by a Male patient taking Sandostatin (View Usage) (Dosage: ) was diagnosed with acromegaly and. Location: GERMANY , weighting 169.8 lb, After Sandostatin was administered, patient had the following side effects: rash erythematous, rash papular, schamberg's disease, skin lesion. Patient was hospitalized.

6567310-3 | Nausea, Nephropathy
on Jan 20, 2010 Male patient from JAPAN , 47 years of age, was diagnosed with acromegaly and was treated with Sandostatin (View Usage). Patient experienced the following unwanted or unexpected effects: nausea (What is nausea?), nephropathy. Sandostatin dosage: 50 Ug Per Day. During the same period patient was treated with INSULIN (Unk) (View Insulin Review and Insulin Label ), PIOGLITAZONE (30 Mg Per Day) (View Pioglitazone Review and Pioglitazone Label ), BROMOCRIPTINE (10 Mg Daily) (View Bromocriptine Review and Bromocriptine Label ), GLIBENCLAMIDE (0.625 Mg Daily) (View Glibenclamide Review and Glibenclamide Label ), VOGLIBOSE (0.6 Mg Per Day) (View Voglibose Review and Voglibose Label ), PEGVISOMANT (10 Mg Per Day) (View Pegvisomant Review and Pegvisomant Label ).

6564780-1 | Rash Erythematous, Rash Papular, Skin Lesion
on Jan 21, 2010 Male patient from GERMANY , weighting 169.8 lb, was diagnosed with acromegaly and was treated with Sandostatin (View Usage). Patient had the following side effects: rash erythematous, rash papular, skin lesion. Sandostatin dosage: . Patient was hospitalized.

6539097-1 | Altered State Of Consciousness, Hyperammonaemic Encephalopathy, Therapeutic Embolisation
Patient was taking Sandostatin (View Usage). After Sandostatin was administered, patient had the following side effects: altered state of consciousness, hyperammonaemic encephalopathy, therapeutic embolisation on Jan 12, 2010 from TURKEY Additional patient health information: Male patient , 53 years of age, . Sandostatin dosage: 0.1 Mg, Tid. During the same period patient was treated with SANDOSTATIN LAR (20 Mg Per 4 Weeks) (View Sandostatin Lar Review and Sandostatin Lar Label ), DOXORUBICIN HCL (60 Mg, Unk) (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), MITOMYCIN (10 Mg, Unk) (View Mitomycin Review and Mitomycin Label ), LIPIODOL (View Lipiodol Review and Lipiodol Label ). Patient was hospitalized.

6523538-X | Rash, Vasculitis
Adverse event was reported on Dec 21, 2009 by a Male patient taking Sandostatin (View Usage) (Dosage: ) was diagnosed with acromegaly and. Location: GERMANY , weighting 169.8 lb, Patient experienced the following unwanted or unexpected effects: rash (What is rash?), vasculitis (What is vasculitis?). Patient was hospitalized.

6519245-X | Arrhythmia, Extrasystoles, Surgery
on Dec 15, 2009 Male patient from GERMANY , 48 years of age, was diagnosed with acromegaly and was treated with Sandostatin (View Usage). Patient had the following side effects: arrhythmia (What is arrhythmia?), extrasystoles, surgery (What is surgery?). Sandostatin dosage: 50 Ug, Tiw. Patient was hospitalized.

6507183-8 | Depression, Diarrhoea, Erythema, Eye Oedema, Eye Pain, Fatigue, Headache, Hypertension, Hyperthyroidism
on Dec 10, 2009 Male patient from BRAZIL , weighting 198.4 lb, was diagnosed with neuroendocrine tumour, hypertension, depression (What is depression?) and was treated with Sandostatin (View Usage). After Sandostatin was administered, patient had the following side effects: depression (What is depression?), diarrhoea, erythema, eye oedema, eye pain, fatigue, headache (What is headache?), hypertension, hyperthyroidism. Sandostatin dosage: Unk. During the same period patient was treated with SANDOSTATIN LAR (30 Mg, Qmo) (View Sandostatin Lar Review and Sandostatin Lar Label ), ATENOLOL (1 Tablet Daily) (View Atenolol Review and Atenolol Label ), LEXAPRO (1 Tablet Daily) (View Lexapro Review and Lexapro Label ). Patient was hospitalized.

6507161-9 | Liver Operation, Pruritus
Patient was taking Sandostatin (View Usage). Patient experienced the following unwanted or unexpected effects: liver operation, pruritus on Dec 10, 2009 from CANADA Additional patient health information: Male patient , 63 years of age, . Sandostatin dosage: . During the same period patient was treated with SANDOSTATIN LAR (20 Mg Every 4 Weeks) (View Sandostatin Lar Review and Sandostatin Lar Label ).

6489985-X | Diarrhoea, Hepatic Failure, Hot Flush, Malignant Neoplasm Progression
Adverse event was reported on Dec 08, 2009 by a Female patient taking Sandostatin (View Usage) (Dosage: 30 Mg, Every 3 Weeks) was diagnosed with carcinoid syndrome and. Location: UNITED STATES , weighting 130.0 lb, Patient had the following side effects: diarrhoea, hepatic failure, hot flush, malignant neoplasm progression.

6442724-0 | Caesarean Section
on Oct 13, 2009 Female patient from CHINA , weighting 154.3 lb, was diagnosed with pancreatitis acute and was treated with Sandostatin (View Usage). After Sandostatin was administered, patient had the following side effects: caesarean section. Sandostatin dosage: 1.2 Mg/day.

6412620-3 | Gallbladder Pain
on Oct 14, 2009 Male patient from UNITED KINGDOM , weighting 209.9 lb, was diagnosed with acromegaly, pituitary tumour, hypertension, hypothyroidism, hypopituitarism and was treated with Sandostatin (View Usage). Patient experienced the following unwanted or unexpected effects: gallbladder pain. Sandostatin dosage: 20 Mg, Unk. During the same period patient was treated with ASPIRIN (75 Mg, Unk) (View Aspirin Review and Aspirin Label ), PERINDOPRIL (8 Mg, Daily) (View Perindopril Review and Perindopril Label ), AMLODIPINE (10 Mg, Daily) (View Amlodipine Review and Amlodipine Label ), LEVOTHYROXINE SODIUM (75 Ug, Daily) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), NORPROLAC (75 Mg, Unk) (View Norprolac Review and Norprolac Label ), TESTOSTERONE (NEBIDO) (Unk) (View Testosterone (nebido) Review and Testosterone (nebido) Label ). Patient was hospitalized.

6410860-0 | Anuria
Patient was taking Sandostatin (View Usage). Patient had the following side effects: anuria on Oct 13, 2009 from CHINA Additional patient health information: Male patient , 78 years of age, was diagnosed with hepatic neoplasm malignant, hepatic cirrhosis and. Sandostatin dosage: 12 Df, Qd, (50ug/h Daily).

6409196-3 | White Blood Cell Count Decreased
Adverse event was reported on Oct 13, 2009 by a Male patient taking Sandostatin (View Usage) (Dosage: 300 Ug/day) was diagnosed with gastrointestinal obstruction, gastric cancer and. Location: JAPAN , 55 years of age, After Sandostatin was administered, patient had the following side effects: white blood cell count decreased. During the same period patient was treated with TS 1 (View Ts 1 Review and Ts 1 Label ), CISPLATIN (6 Mg/m^2) (View Cisplatin Review and Cisplatin Label ).

6404548-X | White Blood Cell Count Decreased
on Oct 07, 2009 Male patient from JAPAN , 55 years of age, was diagnosed with gastrointestinal obstruction, gastric cancer and was treated with Sandostatin (View Usage). Patient experienced the following unwanted or unexpected effects: white blood cell count decreased. Sandostatin dosage: 300 Ug/day. During the same period patient was treated with TS 1 (View Ts 1 Review and Ts 1 Label ), CISPLATIN (6 Mg/m^2) (View Cisplatin Review and Cisplatin Label ).

6401385-7 | Hypotension, Oedema Peripheral, Swelling Face, Swollen Tongue
on Oct 07, 2009 Female patient from UNITED STATES , 55 years of age, was diagnosed with diarrhoea and was treated with Sandostatin (View Usage). Patient had the following side effects: hypotension, oedema peripheral, swelling face, swollen tongue. Sandostatin dosage: 50 Ug, Unk. Patient was hospitalized.

6382144-0 | Altered State Of Consciousness, Hyperammonaemic Encephalopathy
Patient was taking Sandostatin (View Usage). After Sandostatin was administered, patient had the following side effects: altered state of consciousness, hyperammonaemic encephalopathy on Sep 23, 2009 from TURKEY Additional patient health information: Male patient , 53 years of age, . Sandostatin dosage: 0.1 Mg, Tid. During the same period patient was treated with SANDOSTATIN LAR (20 Mg Per 4 Weeks) (View Sandostatin Lar Review and Sandostatin Lar Label ), DOXORUBICIN HCL (60 Mg, Unk) (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), MITOMYCIN (10 Mg, Unk) (View Mitomycin Review and Mitomycin Label ), LIPIODOL (View Lipiodol Review and Lipiodol Label ).

6373997-0 | Pregnancy
Adverse event was reported on Sep 22, 2009 by a Female patient taking Sandostatin (View Usage) (Dosage: 30mg Monthly Im) was diagnosed with acromegaly and. Location: UNITED STATES , weighting 173.0 lb, Patient experienced the following unwanted or unexpected effects: pregnancy (What is pregnancy?).

6347320-1 | Blood Glucose Decreased, Post Procedural Infection
on Sep 02, 2009 Female patient from JAPAN , 52 years of age, was diagnosed with pancreatic leak and was treated with Sandostatin (View Usage). Patient had the following side effects: blood glucose decreased, post procedural infection. Sandostatin dosage: 300 Ug, Tid.

6330343-6 | Abdominal Pain Upper, Chest Pain
on Aug 26, 2009 Female patient from UNITED STATES , 26 years of age, weighting 135.0 lb, was diagnosed with acromegaly and was treated with Sandostatin (View Usage). After Sandostatin was administered, patient had the following side effects: abdominal pain upper, chest pain (What is chest pain?). Sandostatin dosage: 30mg Once Monthly Im, Less Than 1 Year. Patient was hospitalized.

6309713-8 | Muscle Atrophy
Patient was taking Sandostatin (View Usage). Patient experienced the following unwanted or unexpected effects: muscle atrophy on Aug 07, 2009 from JAPAN Additional patient health information: Female patient , 48 years of age, was diagnosed with chylothorax and. Sandostatin dosage: 200 To 800 Ug Per Day. During the same period patient was treated with ELASPOL (Unk) (View Elaspol Review and Elaspol Label ), PROPOFOL (Unk) (View Propofol Review and Propofol Label ). Patient was hospitalized.

6302722-4 | Atrial Fibrillation, Cardiac Pacemaker Insertion, Dizziness, Dyspnoea, Loss Of Consciousness, Sick Sinus Syndrome, Ventricular Extrasystoles
Adverse event was reported on Aug 03, 2009 by a Female patient taking Sandostatin (View Usage) (Dosage: 200 Ug Daily) was diagnosed with acromegaly, hypertension, diabetes mellitus, dyslipidaemia, insomnia and. Location: JAPAN , weighting 143.3 lb, Patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), cardiac pacemaker insertion, dizziness (What is dizziness?), dyspnoea, loss of consciousness, sick sinus syndrome, ventricular extrasystoles. During the same period patient was treated with ATENOLOL (50 Mg) (View Atenolol Review and Atenolol Label ), NICERGOLINE (5 Mg) (View Nicergoline Review and Nicergoline Label ), ACTOS (15 Mg) (View Actos Review and Actos Label ), ENALAPRIL MALEATE (5 Mg) (View Enalapril Maleate Review and Enalapril Maleate Label ), AMLODIN (5 Mg) (View Amlodin Review and Amlodin Label ), PRAVASTATIN SODIUM (5 Mg) (View Pravastatin Sodium Review and Pravastatin Sodium Label ), BROTIZOLAM (0.25 Mg) (View Brotizolam Review and Brotizolam Label ). Patient was hospitalized.

6301084-6 | Oliguria, Renal Failure
on Jul 28, 2009 Male patient from CHINA , 70 years of age, weighting 123.5 lb, was diagnosed with pancreatitis acute and was treated with Sandostatin (View Usage). After Sandostatin was administered, patient had the following side effects: oliguria, renal failure. Sandostatin dosage: 0.5 Mg Per 12 Hour. During the same period patient was treated with ANTIBIOTICS (View Antibiotics Review and Antibiotics Label ). Patient was hospitalized.

6299893-5 | Thrombocytopenia
on Jul 29, 2009 Male patient from UNITED STATES , 53 years of age, was diagnosed with oesophageal varices haemorrhage and was treated with Sandostatin (View Usage). Patient experienced the following unwanted or unexpected effects: thrombocytopenia. Sandostatin dosage: 50 Ug, Unk. During the same period patient was treated with PANTOPRAZOLE SODIUM (80 Mg) (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), THIAMINE HCL (View Thiamine Hcl Review and Thiamine Hcl Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), CIPROFLOXACIN HYDROCHLORIDE (View Ciprofloxacin Hydrochloride Review and Ciprofloxacin Hydrochloride Label ), CHLORDIAZEPOXIDE (View Chlordiazepoxide Review and Chlordiazepoxide Label ), ESOMEPRAZOLE (View Esomeprazole Review and Esomeprazole Label ), PROPRANOLOL (1) (View Propranolol Review and Propranolol Label ). Patient was hospitalized.

6262339-7 | Dyspnoea, Pulmonary Arterial Hypertension
Patient was taking Sandostatin (View Usage). Patient had the following side effects: dyspnoea, pulmonary arterial hypertension on Jun 30, 2009 from FRANCE Additional patient health information: Female patient , 46 years of age, . Sandostatin dosage: 25 Mg/h For 3 Days. During the same period patient was treated with SANDOSTATIN LAR (30 Mg Every 14 Days) (View Sandostatin Lar Review and Sandostatin Lar Label ).